SEARCH

SEARCH BY CITATION

References

  • 1
    Alarco, A.-M., Balan, I., Talibi, D., Mainville, N., Raymond, M. (1997) AP1-mediated multidrug resistance in Saccharomyces cerevisiae requires FLR1 encoding a transporter of the major facilitator superfamily. J Biol Chem 272: 1930419313.
  • 2
    Ausubel, F.M., Brent, R., Kingston, R.E., Moore, D.D., Seidman, J.G., Smith, J.A., et al. (eds) (1989) Current Protocols in Molecular Biology. New York: John Wiley & Sons.
  • 3
    Balzi, E., Wang, M., Leterme, S., Van Dyck, L., Goffeau, A. (1994) PDR5, a novel yeast multidrug resistance conferring transporter controlled by the transcriptional regulator PDR1. J Biol Chem 269: 22062214.
  • 4
    Ben-Yaacov, R., Knoller, S., Caldwell, G.A., Becker, J.M., Koltin, Y. (1994) Candida albicans gene encoding resistance to benomyl and methotrexate is a multidrug resistance gene. Antimicrob Agents Chemother 38: 648652.
  • 5
    Boeke, J.D., Lacroute, F., Fink, G.R. (1984) A positive selection for mutants lacking orotidine-5′-phosphate decarboxylase activity in yeast: 5-fluoro-orotic acid resistance. Mol Gen Genet 197: 345346.
  • 6
    Calderone, R.A. & Braun, P.C. (1991) Adherence and receptor relationships of Candida albicans. Microbiol Rev 55: 120.
  • 7
    Carvajal, E., Van Den Hasel, H.B., Cybularz-Kalaczkowska, A., Balzi, E., Goffeau, A. (1997) Molecular and phenotypic characterization of yeast PDR1 mutants that show hyperactive transcription of various ABC multidrug transporter genes. Mol Gen Genet 256: 406415.
  • 8
    Coleman, S.T., Tseng, E., Moye-Rowley, W.S. (1997) Saccharomyces cerevisiae basic region-leucine zipper protein regulatory networks converge at the ATR1 structural gene. J Biol Chem 272: 2322423230.
  • 9
    Fling, M.E., Kopf, J., Tamarkin, A., Gorman, J.A., Smith, H.A., Koltin, Y. (1991) Analysis of a Candida albicans gene that encodes a novel mechanism for resistance to benomyl and methothrexate. Mol Gen Genet 227: 318329.
  • 10
    Fonzi, W.A. & Irwin, M.Y. (1993) Isogenic strain construction and gene mapping in Candida albicans. Genetics 134: 717728.
  • 11
    Franz, R., Kelly, S.L., Lamb, D.C., Kelly, D.E., Ruhnke, M., Morschhäuser, J. (1998) Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains. Antimicrob Agents Chemother 42: 30653072.
  • 12
    Franz, R., Ruhnke, M., Morschhäuser, J. (1999) Molecular aspects of fluconazole resistance development in Candida albicans. Mycoses 42: 453458.
  • 13
    Ghannoum, M.A., Rex, J.H., Galgiani, J.N. (1996) Susceptibility testing of fungi: current status of correlation of in vitro data with clinical outcome. J Clin Microbiol 34: 489495.
  • 14
    Goffeau, A., Park, J., Paulsen, I.T., Jonniaux, J.-L., Dinh, T., Mordant, P., et al. (1997) Multidrug-resistant transport proteins in yeast: complete inventory and phylogenetic characterization of yeast open reading frames within the major facilitator superfamily. Yeast 13: 4354.
  • 15
    Hube, B., Monod, M., Schofield, D.A., Brown, A.J.P., Gow, N.A.R. (1994) Expression of seven members of the gene family encoding secretory aspartyl proteinases in Candida albicans. Mol Microbiol 14: 8799.
  • 16
    Ibrahim, A.S., Mirbod, F., Filler, S.G., Banno, Y., Cole, G.T., Kitayima, Y., et al. (1995) Evidence implicating phospholipase as a virulence factor of Candida albicans. Infect Immun 63: 19931998.
  • 17
    Katzmann, D.J., Burnett, P.E., Golin, J., Mahé, Y., Moye-Rowley, W.S. (1994) Transcriptional control of the yeast PDR5 gene by the PDR3 gene product. Mol Cell Biol 14: 46534661.
  • 18
    Katzmann, D.J., Hallstrom, T.C., Voet, M., Wysock, W., Golin, J., Volckaert, G., et al. (1995) Expression of an ATP-binding cassette transporter-encoding gene (YOR1) is required for oligomycin-resistance in Saccharomyces cerevisiae. Mol Cell Biol 15: 68756883.
  • 19
    Kondoh, Y., Shimizu, K., Tanaka, K. (1987) Proteinase production and pathogenicity of Candida albicans. II. Virulence for mice of C. albicans strains of different proteinase activity. Microbiol Immunol 31: 10611069.
  • 20
    Köhler, G.A., White, T.C., Agabian, N. (1997) Overexpression of a cloned IMP dehydrogenase gene of Candida albicans confers resistance to the specific inhibitor mycophenolic acid. J Bacteriol 179: 23312338.
  • 21
    Lay, J., Henry, L.K., Clifford, J., Koltin, Y., Bulawa, C.E., Becker, J.M. (1998) Altered expression of selectable marker URA3 in gene-disrupted Candida albicans strains complicates interpretation of virulence studies. Infect Immun 66: 53015306.
  • 22
    Lopez-Ribot, J.L., McAtee, R.K., Lee, L.N., Kirkpatrick, W.R., White, T.C., Sanglard, D., et al. (1998) Distinct patterns of gene expression associated with development of fluconazole resistance in serial Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis. Antimicrob Agents Chemother 42: 29322937.
  • 23
    Mahé, Y., Parle-McDermott, A., Nourani, A., Delahodde, A., Lamprecht, A., Kuchler, K. (1996) The ATP-binding cassette multidrug transporter Snq2 of Saccharomyces cerevisiae: a novel target for the transcription factors Pdr1 and Pdr3. Mol Microbiol 20: 109117.
  • 24
    Meyers, S., Schauer, W., Balzi, E., Wagner, M., Goffeau, A., Golin, J. (1992) Interaction of the yeast pleiotropic drug resistance genes PDR1 and PDR5. Curr Genet 21: 431436.
  • 25
    Millon, L., Manteaux, A., Reboux, G., Drobacheff, C., Monod, M., Barale, T., et al. (1994) Fluconazole-resistant recurrent oral candidiasis in human immunodeficiency virus-positive patients: persistence of Candida albicans strains with the same genotype. J Clin Microbiol 32: 11151118.
  • 26
    Morschhäuser, J., Michel, S., Staib, P. (1999) Sequential gene disruption in Candida albicans by FLP-mediated site-specific recombination. Mol Microbiol 32: 547556.
  • 27
    Nourani, A., Papajova, D., Delahodde, A., Jacq, C., Subik, J. (1997a) Clustered amino acid substitutions in the yeast transcription regulator Pdr3p increase pleiotropic drug resistance and identify a new central regulatory domain. Mol Gen Genet 256: 397405.
  • 28
    Nourani, A., Wesolowski-Louvel, M., Delaveau, T., Jacq, C., Delahodde, A. (1997b) Multiple-drug-resistance phenomenon in the yeast Saccharomyces cerevisiae: involvement of two hexose transporters. Mol Cell Biol 17: 54535460.
  • 29
    Odds, F.C. (1988) Candida and Candidosis. London: Baillière Tindall.
  • 30
    Rex, J.H., Rinaldi, M.G., Pfaller, M.A. (1995) Resistance of Candida species to fluconazole. Antimicrob Agents Chemother 39: 18.
  • 31
    Ruhnke, M., Eigler, A., Tennagen, I., Geiseler, B., Engelmann, E., Trautmann, M. (1994) Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection. J Clin Microbiol 32: 20922098.
  • 32
    Sanglard, D., Kuchler, K., Ischer, F., Pagani, J.-L., Monod, M., Bille, J. (1995) Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob Agents Chemother 39: 23782386.
  • 33
    Sanglard, D., Ischer, F., Monod, M., Bille, J. (1996) Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors. Antimicrob Agents Chemother 40: 23002305.
  • 34
    Sanglard, D., Ischer, F., Monod, M., Bille, J. (1997) Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene. Microbiology 143: 405416.
  • 35
    Sanglard, D., Ischer, F., Koymans, L., Bille, J. (1998) Amino acid substitutions in the cytochrome P-450 lanosterol 14α-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents. Antimicrob Agents Chemother 42: 241253.
  • 36
    Soll, D.R., Morrow, B., Srikantha, T. (1993) High-frequency phenotypic switching in Candida albicans. Trends Genet 9: 6165.
  • 37
    Staib, P., Kretschmar, M., Nichterlein, T., Köhler, G., Michel, S., Hof, H., et al. (1999) Host-induced, stage-specific virulence gene activation in Candida albicans during infection. Mol Microbiol 32: 533546.
  • 38
    Talibi, D. & Raymond, M. (1999) Isolation of a putative Candida albicans transcriptional regulator involved in pleiotropic drug resistance by functional complementation of a pdr1 pdr3 mutation in Saccharomyces cerevisiae. J Bacteriol 181: 231240.
  • 39
    Vanden Bossche, H., Marichal, P., Odds, F.C. (1994) Molecular mechanisms of drug resistance in fungi. Trends Microbiol 2: 393400.
  • 40
    Wemmie, J.A., Szczypka, M.S., Thiele, D.J., Moye-Rowley, W.S. (1994) Cadmium tolerance mediated by the yeast AP-1 protein requires the presence of an ATP-binding cassette transporter-encoding gene YCF1. J Biol Chem 269: 3259232597.
  • 41
    White, T.C. (1997a) Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus. Antimicrob Agents Chemother 41: 14821487.
  • 42
    White, T.C. (1997b) The presence of an R467K amino acid substitution and loss of allelic variation correlate with an azole-resistant lanosterol 14α demethylase in Candida albicans. Antimicrob Agents Chemother 41: 14881494.
  • 43
    Wirsching, S., Michel, S., Köhler, G., Morschhäuser, J. (2000) Activation of the multiple drug resistance gene MDR1 in fluconazole-resistant, clinical Candida albicans strains is caused by mutations in a trans-regulatory factor. J Bacteriol 182: 400404.
  • 44
    Wolfger, H., Mahé, Y., Parle-McDermott, A., Delahodde, A., Kuchler, K. (1997) The yeast ATP binding cassette (ABC) protein genes PDR10 and PDR15 are novel targets for the Pdr1 and Pdr3 transcriptional regulators. FEBS Lett 418: 269274.